Listed by the USPTO as SKIBINSKY, ANNA
Tech Center 1600 • Art Units: 1631 1635 1687
This examiner grants 39% of resolved cases
SKIBINSKY, ANNA is assigned to Tech Center 1600 and art unit 1631. The record includes 691 resolved cases and an allowance rate of 39.1%. Interview activity shows a 29.3% lift, below the allowance rate but still relevant to prosecution planning. The median time to allowance is 1647 days, the longest timing measure in the profile, which makes early development of claim and amendment strategy particularly important.
The listed companies are Elucid Bioimaging Inc., Compass Pathfinder Limited, and Sony Group Corporation. The listed firms are FISH & RICHARDSON P.C. (TC), BOSE MCKINNEY & EVANS LLP, and BrainSpark Associates, LLC. Counsel may benefit from focused interviews, detailed technical distinctions, and preserved fallback positions when managing applications in this art unit.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18030305 | BIOPARTICLE SORTING APPARATUS AND INFORMATION PROCESSING APPARATUS | Non-Final OA | Sony Group Corporation |
| 18044541 | IDENTIFYING THE PRESENCE OF METASTATIC CANCER AND TISSUE OF ORIGIN WITH MICROBIAL NUCLEIC ACIDS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18558955 | SYSTEMS AND METHODS FOR ESTIMATING, FROM FOOD FREQUENCY QUESTIONNAIRE BASED NUTRIENTS INTAKE DATA, THE RELATIVE AMOUNTS OF FAECALIBACTERIUM PRAUSNITZII (FPRAU) IN THE GUT MICROBIOME ECOSYSTEM AND ASSOCIATED RECOMMENDATIONS TO IMPROVE FAECALIBACTERIUM PRAUSNITZII | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 17685453 | Microorganism Discrimination Method and System | Non-Final OA | SHIMADZU CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy39.1% of resolved applications examined by Anna Skibinsky were allowed (691 resolved cases), compared with 28.4% across Art Unit 1631 over the last five years.
This examiner's interview lift is +29.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Anna Skibinsky took 1,647 days on average from filing to allowance.
Anna Skibinsky examines applications in Art Unit 1631 in Tech Center 1600 (Biotechnology & Pharmaceuticals).